Most likely, inflammation does not cause AMD in the first place, but it does manifest in early AMD pathology, which may help to explain why anti-inflammatory drugs work well as preventive or supplemental treatments when combined with anti-VEGF therapy, photodynamic therapy, or both [81]. This evidence concerns the gene VEGFA and age-related macular degeneration.